What does Canopy Growth do?
Canopy Growth is a Canadian cannabis company that produces and sells a wide range of cannabis products, including dried flowers, oils, capsules, and vape cartridges. The company also has a portfolio of brands, including Tweed, Spectrum Therapeutics, and Tokyo Smoke. Canopy Growth operates across multiple countries, including Canada, the United States, Germany, and the United Kingdom, and is focused on expanding its global presence in the legal cannabis industry. The company is also involved in research and development of new cannabis-based products, as well as partnerships with other companies in the industry.
What is Canopy Growth’s ticker symbol?
Canopy Growth’s stock trades on the Toronto Stock Exchange (TSX) and the NASDAQ. On the TSX, the ticker symbol is “WEED”, and on the NASDAQ, it is “CGC”.
Where is Canopy Growth based?
Canopy Growth is based in Smiths Falls, Ontario, Canada.
Who are the major shareholders of Canopy Growth?
As of its latest available public filings, the top institutional shareholders of Canopy Growth Corporation are The Vanguard Group, Inc., Constellation Brands, Inc., and BlackRock, Inc. The top individual shareholders are its former CEO Bruce Linton, and its current CEO David Klein.
Does Canopy Growth have strong margins?
Canopy Growth Corporation is a Canadian cannabis company that operates in a highly regulated industry with significant costs and constraints. As of the latest financial statements available (Q3 2022), Canopy Growth reported a gross margin of 10%, which is relatively low compared to other industries but is common for companies in the cannabis industry. The company’s net loss margin for the same period was -69%, indicating that the company is not currently profitable. It’s worth noting that the cannabis industry is still in the early stages of development, and many companies are still investing heavily in research and development, production capacity, and marketing to capture market share, which may impact their profitability in the short term.
Who are Canopy Growth’s competitors?
Canopy Growth’s competitors include other major cannabis producers such as Aurora Cannabis, Tilray, Cronos Group, and Aphria.
Do analysts like Canopy Growth stock?
It’s difficult to provide a definitive answer on whether analysts like Canopy Growth stock, as opinions can vary among different analysts and can change over time. However, here are some recent analyst ratings and price targets for Canopy Growth:
- According to MarketBeat, as of April 16, 2023, the consensus rating among 17 Wall Street analysts covering Canopy Growth is a “hold,” with an average price target of $19.90.
- Among the 15 analysts tracked by CNN Business, as of April 16, 2023, the consensus rating for Canopy Growth is a “hold,” with an average price target of $20.87.
It’s worth noting that analyst opinions can be influenced by a variety of factors, including market conditions, company performance, and industry trends. Investors should always conduct their own research and consider multiple sources of information before making investment decisions.
Here are some analysts who cover Canopy Growth and their price targets as of my knowledge cutoff date (September 2021):
- BMO Capital Markets: Price target of CAD 34
- Cowen and Company: Price target of USD 30
- Jefferies Financial Group: Price target of USD 38
- Piper Sandler: Price target of USD 35
- RBC Capital Markets: Price target of CAD 42
- Stifel Nicolaus: Price target of USD 33
Please keep in mind that these price targets may have changed since then and that this is not an exhaustive list of all analysts covering Canopy Growth.
The information provided in this article is for educational and informational purposes only and should not be construed as investment advice. The content of this article is not intended to provide investment, financial, or legal advice and should not be relied upon as such. The author and the publisher of this article are not registered investment advisors or broker-dealers and do not purport to provide personalized investment advice. Any investment decisions that you make based on the information contained in this article are at your own risk. It is recommended that you consult with a qualified investment advisor, accountant, and/or attorney before making any investment decisions. The author and the publisher of this article are not responsible for any investment losses that you may incur as a result of using the information contained in this article.